CMIC’s Singapore office was established in 2006 as the CMIC’s Asia Pacific headquarters to provide full operational services in the execution of clinical trials under the Pharmaceutical Value Creator (PVC) model. With more than 5 years’ experience in the Southeast Asia region and beyond for projects of global and local scales, we understand the region’s biopharmaceutical and healthcare markets.
Our combination of industry experience and expertise across a broad spectrum of therapeutic areas and phases can help you accelerate clinical and commercial success to deliver better medicines, sooner.
Singapore is a small country—sites are densely populated and have a diverse patient population. Although this may mean a high number of competing trials, CMIC carefully selects sites in accordance with protocol traits, accessing a sufficient patient pool.
Regulatory consultation and dossier submission to health authorities (HA) and ethics committees (EC)
Clinical monitoring and site management
Full Biometrics support and Clinical Study Report (CSR) writing
Pharmacovigilance and medical monitoring
Quality assurance and quality compliance services
Facility Contact Information
6 Shenton Way #23-09 OUE Downtown 2 Singapore 068809
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.